O.V. Kuryata, Ye.O. Frolova, T.D. Yashenko

Clinical efficacy and safety Furamag in the combined antibacterial therapy of chronic pyelonephritis. The sensitivity profile of UTIs to antibacterial drugs of different classes

The article presents the results of a study of the effectiveness of the drug furazidin K (Furamag, OLFA, Latvia) in the treatment of exacerbation of chronic uncomplicated and complicated pyelonephritis. The results of the study allow us to recommend it for further widespread use in clinical nephrology for the treatment of patients with UTIs (urinary tract infections). High therapeutic efficacy and safety of the use of the drug furazidin K (Furamag, OLFA, Latvia) in the treatment of patients with exacerbation of chronic uncomplicated and complicated pyelonephritis was noted.